UroGen Pharma Ltd. (NASDAQ:URGN) Receives $32.86 Average PT from Analysts
Shares of UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report) have received an average rating of “Buy” from the eight brokerages that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. […]
Shares of UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report) have received an average rating of “Buy” from the eight brokerages that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. […]
